Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
BEAM compared with AMGN: revenue, margins and what each company keeps, and the suppliers and customers both name
BEAM
Beam Therapeutics Inc.
Change
Mkt cap
Revenue
Revenue
AMGN
Amgen Inc
Change
Mkt cap
Revenue
Revenue
vs
Compare
BEAM
Beam Therapeutics Inc.
vs
AMGN
Amgen Inc
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Price
Desk
News
Calendar
Saved
Search
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
BEAM, solid
AMGN, dashed
BEAM
Beam Therapeutics Inc.
Change
25.85
· pre 25.34
· delayed
Mkt cap
$2.7B
Revenue
$490,000
Q2 FY26
Revenue
$140M
FY25
AMGN
Amgen Inc
Change
465.45
· pre 462.95
· delayed
Pre-market
Nov 3 '26
delayed
Mkt cap
$251.6B
Revenue
$10.1B
Q2 FY26
Revenue
$36.8B
FY25
vs
Compare
Pre-market
Nov 3 '26
delayed
BEAM
Beam Therapeutics Inc.
vs
AMGN
Amgen Inc
25.85
pre 25.34
delayed
Price
465.45
pre 462.95
delayed
$2.7B
Mkt cap
$251.6B
Q2 FY26
$490,000
Revenue
$10.1B
Q2 FY26
FY25
$140M
Revenue
$36.8B
FY25
Change
Change
BEAM
25.85
vs
AMGN
465.45
Pre-market
Nov 3 '26
delayed